RDY Projected Dividend Yield

ADR/Dr. Reddy's Laboratories Ltd. ( NYSE : RDY )

Dr. Reddy's Laboratories is a pharmaceutical company. Co.'s segments include: Global Generics, which includes its business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics); Pharmaceutical Services and Active Ingredients, which includes its business of manufacturing and marketing active pharmaceutical ingredients and intermediates; and Proprietary Products, which includes its business that focuses on the research and development of differentiated formulations.

22 YEAR PERFORMANCE RESULTS